Table 2.
CIN group | Non-CIN group | |
---|---|---|
Serum SCr (umol/L) | ||
0 h | 65.84±7.31 | 68.25±10.52 |
6 h | 71.18±9.23 | 69.83±11.95 |
12 h | 85.52±11.09 | 73.26±10.86 |
24 h | 105.87±44.42 | 72.89±10.73 |
48 h | 116.35±43.04 | 77.98±11.97 |
Between groups | F=112.894, P<0.05 | |
Between time points | F=36.380, P<0.05 | |
Between groups*Between time points | F=22.173, P<0.05 | |
Serum NGAL(ng/mL) | ||
0 h | 86.78±13.96 | 87.69±15.85 |
6 h | 126.05±55.41 | 88.87±4.23 |
12 h | 167.27±89.37 | 88.05±5.26 |
24 h | 162.84±76.28 | 89.12±5.35 |
48 h | 123.36±55.42 | 87.53±4.98 |
Between groups | F=208.156, P<0.05 | |
Between time points | F=37.825, P<0.05 | |
Between groups*Between time points | F=24.392, P<0.05 | |
Urine KIM-1 (ng/L) | ||
0 h | 28.28±4.47 | 27.35±3.96 |
6 h | 64.33±9.58 | 37.32±6.45 |
12 h | 74.23±10.86 | 40.19±9.47 |
24 h | 71.46±9.62 | 41.31±7.63 |
48 h | 54.52±7.87 | 39.02±6.01 |
Between groups | F=98.261, P<0.05 | |
Between time points | F=21.473, P<0.05 | |
Between groups*Between time points | F=23.348, P<0.05 |
P<0.05 suggested statistically significant.